Upcoming Events
Annual Meeting of Stockholders
Jun 16, 2020 • 9:00 am PDT
San Francisco, CA
American Association for Cancer Research (AACR) Virtual Annual Meeting II 2020
Jun 22 – Jun 24, 2020
Past Events
6th European Academy of Neurology (EAN) Annual Congress - Atara Conference Call and Webcast
May 26, 2020 • 8:00 am EDT
First Quarter 2020 Financial Results Conference Call
May 6, 2020 • 4:30 pm EDT
Barclays Global Healthcare Conference
Mar 11, 2020 • 11:45 am EDT
Loews Miami Beach Hotel in Miami Beach, FL
Cowen 40th Annual Health Care Conference
Mar 2, 2020 • 4:10 pm EDT
Boston Marriott Copley Place in Boston, MA
Fourth Quarter 2019 Financial Results Conference Call
Feb 27, 2020 • 8:00 am EDT
2020 TCT | Transplantation & Cellular Therapy Meetings
Feb 19 – Feb 23, 2020
Orlando, Florida
Abstract 413: A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease (EBV+PTLD) after Failure of Rituximab or Rituximab and Chemotherapy
Poster Presentation Date and Time: Saturday, February 22, 2020; 6:15 - 7:45 p.m. EST
Session Title: Poster Session II: Cellular and Gene Therapy: Clinical/Processing
Location: World Center Marriott - Palms & Cypress Foyers
Authors: Susan Prockop, M.D.1, Minoti Hiremath, MBBS, Ph.D.2, Wei Ye, Ph.D.2, Laurence Gamelin, Ph.D.2, Willis H. Navarro, M.D.2, Kris Michael Mahadeo, M.D.3
Affiliations: 1Memorial Sloan Kettering Cancer Center, New York, NY; 2Atara Biotherapeutics, South San Francisco, CA; 3MD Anderson Cancer Center, Houston, TX
38th Annual J.P. Morgan Healthcare Conference
Jan 16, 2020 • 8:30 am PDT
Westin St. Francis Hotel in San Francisco
61st American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 7 – Dec 10, 2019
Orlando, Florida